Bioactivity | Topoisomerase II inhibitor 13 is a topoisomerase II (Topo II) inhibitor. Topoisomerase II inhibitor 13 shows antiproliferative activity against several cancer cells. Topoisomerase II inhibitor 13 induces cancer cells apoptosis[1]. | ||||||||||||
Invitro | Topoisomerase II inhibitor 13 (compound 3m) (20 μM,50 μM) 在 20 μM 时发挥强烈的抑制作用,几乎完全抑制 Topo II 活性[1]。Topoisomerase II inhibitor 13 抑制癌细胞增殖,IC50 分别为 25.85 μM (MDA-MB-231)、1.82 μM (A549)、10.38 μM (K562)、1.73 μM (Raji)、1.23 μM (HL-60) 和 0.87 μM (HL-60/MX2)[1]。 | ||||||||||||
Name | Topoisomerase II inhibitor 13 | ||||||||||||
CAS | 451515-89-2 | ||||||||||||
Formula | C22H23N9 | ||||||||||||
Molar Mass | 413.48 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Li P H, et al. Synthesis and mechanism studies of 1, 3-benzoazolyl substituted pyrrolo [2, 3-b] pyrazine derivatives as nonintercalative topoisomerase II catalytic inhibitors. Journal of Medicinal Chemistry, 2016, 59(1): 238-252. |